Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab

A. Fromont, R.O. Casasnovas, C. Billy, L. Martin, Thibault Moreau. Favorable evolution post hematologous stem cell transplant after primary central nervous system lymphoma in a multiple sclerosis under natalizumab . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Oct 2017, Paris, France. , Multiple Sclerosis Journal 2017; 23: (S3) 680–975, 23 (S3), pp.EP1760. ⟨hal-01678280⟩